London, United Kingdom
Neurocess Limited, founded in 2018 and headquartered in the United Kingdom, is a forward-thinking player in the Hardware and Autonomous and Sensor Tech industries. With the slogan "Optimise Training, Prevent Injury", Neurocess aims to revolutionize athletic training and injury prevention specifically for football players.
The company offers a cutting-edge network of sensors designed to monitor various parameters of athletic and physiological performance. The proprietary technology features the world's smallest, wireless, clinical-level, dry, active EMG sensors. This allows for real-time, long-distance data transmission from up to 30 athletes simultaneously, making it perfectly suited for the football environment.
Neurocess last secured a $3.40M Seed Round investment on 05 April 2021. The round was backed by notable investors including SOSV, HAX, Growth Circuit, and Diffusion Capital Partners. This investment positions Neurocess for continued growth and technological advancement in its niche market.
